Activist 13D/13G Filings - INTEGRATED CORE STRATEGIES (US) LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, ...38, 39, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-02-15
4:17 pm
Purchase
13GHelix Acquisition Corp. II Class A Ordinary Shares
HLXB
INTEGRATED CORE STRATEGIES (US) LLC1,100,000
5.8%
1,100,000increase
(New Position)
View
2024-02-14
4:08 pm
Sale
13GAlpha Partners Technology Merger Corp.
APTM
INTEGRATED CORE STRATEGIES (US) LLC1,324,566
8.5%
-1,150,434decrease
(-46.48%)
View
2024-02-12
4:35 pm
Purchase
13GUnited Homes Group, Inc.
UHG
INTEGRATED CORE STRATEGIES (US) LLC208,963
1.8%
208,963increase
(New Position)
View
2024-02-12
4:24 pm
Sale
13GFreeline Therapeutics Holdings plc
FRLN
INTEGRATED CORE STRATEGIES (US) LLC0
0%
-5,555,085decrease
(Position Closed)
View
2024-02-09
4:11 pm
Purchase
13GCorbus Pharmaceuticals Holdings, Inc.
CRBP
INTEGRATED CORE STRATEGIES (US) LLC419,707
4.1%
419,707increase
(New Position)
View
2024-02-08
4:43 pm
Purchase
13GVapotherm, Inc.
VAPO
INTEGRATED CORE STRATEGIES (US) LLC490,044
7.8%
490,044increase
(New Position)
View
2024-02-08
4:36 pm
Purchase
13GSpyre Therapeutics, Inc.
SYRE
INTEGRATED CORE STRATEGIES (US) LLC108,486
0.3%
108,486increase
(New Position)
View
2024-02-06
4:20 pm
Sale
13GCutera, Inc.
CUTR
INTEGRATED CORE STRATEGIES (US) LLC827,032
4.1%
-663,040decrease
(-44.50%)
View
2024-02-05
4:32 pm
Purchase
13GflyExclusive, Inc.
FLYX
INTEGRATED CORE STRATEGIES (US) LLC37,500
0.2%
37,500increase
(New Position)
View
2024-02-05
4:27 pm
Purchase
13GCarmell Therapeutics Corporation
CTCX
INTEGRATED CORE STRATEGIES (US) LLC235,414
1%
235,414increase
(New Position)
View
2024-02-01
4:25 pm
Sale
13GMaxCyte, Inc.
MXCT
INTEGRATED CORE STRATEGIES (US) LLC5,012,283
4.8%
-758,611decrease
(-13.15%)
View
2024-01-31
4:32 pm
Purchase
13GElevation Oncology, Inc.
ELEV
INTEGRATED CORE STRATEGIES (US) LLC2,990,279
7.1%
1,592,897increase
(+113.99%)
View
2024-01-30
4:25 pm
Sale
13GTKB Critical Technologies 1
USCT
INTEGRATED CORE STRATEGIES (US) LLC0
0%
-992,538decrease
(Position Closed)
View
2024-01-29
4:42 pm
Sale
13GMilestone Pharmaceuticals Inc.
MIST
INTEGRATED CORE STRATEGIES (US) LLC1,730,889
5.2%
-464,140decrease
(-21.15%)
View
2024-01-29
4:36 pm
Sale
13GKala Pharmaceuticals, Inc.
KALA
INTEGRATED CORE STRATEGIES (US) LLC132,674
4.9%
-1,029decrease
(-0.77%)
View
2024-01-26
4:19 pm
Sale
13GLongboard Pharmaceuticals, Inc.
LBPH
INTEGRATED CORE STRATEGIES (US) LLC6,610
0%
-981,102decrease
(-99.33%)
View
2024-01-25
4:09 pm
Purchase
13GTerns Pharmaceuticals, Inc.
TERN
INTEGRATED CORE STRATEGIES (US) LLC3,479,630
5.6%
3,479,630increase
(New Position)
View
2024-01-24
4:16 pm
Sale
13GBioLife Solutions, Inc.
BLFS
INTEGRATED CORE STRATEGIES (US) LLC2,412,650
5.4%
-69,296decrease
(-2.79%)
View
2024-01-23
4:31 pm
Sale
13GMyriad Genetics, Inc.
MYGN
INTEGRATED CORE STRATEGIES (US) LLC3,561,337
4%
-699,704decrease
(-16.42%)
View
2024-01-22
4:15 pm
Sale
13GTwist Bioscience Corporation
TWST
INTEGRATED CORE STRATEGIES (US) LLC1,821,238
3.2%
-1,224,675decrease
(-40.21%)
View
Goto 0, 1, 2, ...38, 39, Next